Log In
BCIQ
Print this Print this
 

MRx109

  Manage Alerts
Collapse Summary General Information
Company MyeloRx LLC
DescriptionImmunosuppressant of T lymphocyte proliferation and cytokine production
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today